INHC Stock Overview
Provides software to healthcare professionals in the United Kingdom.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Induction Healthcare Group PLC Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£0.075 |
52 Week High | UK£0.28 |
52 Week Low | UK£0.065 |
Beta | -0.41 |
11 Month Change | 0% |
3 Month Change | -25.00% |
1 Year Change | -70.59% |
33 Year Change | -85.15% |
5 Year Change | -93.62% |
Change since IPO | -93.72% |
Recent News & Updates
Shareholder Returns
INHC | GB Healthcare Services | GB Market | |
---|---|---|---|
7D | 0% | -1.4% | -0.5% |
1Y | -70.6% | 17.0% | 7.7% |
Return vs Industry: INHC underperformed the UK Healthcare Services industry which returned 17% over the past year.
Return vs Market: INHC underperformed the UK Market which returned 7.7% over the past year.
Price Volatility
INHC volatility | |
---|---|
INHC Average Weekly Movement | 5.0% |
Healthcare Services Industry Average Movement | 5.3% |
Market Average Movement | 4.6% |
10% most volatile stocks in GB Market | 9.3% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: INHC has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: INHC's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2019 | 74 | Paul Antonio Tambeau | www.inductionhealthcare.com |
Induction Healthcare Group PLC provides software to healthcare professionals in the United Kingdom. The company offers Zesty, a patient engagement platform that provides smart appointment management, paperless letters, targeted questionnaires, and patient information; and Attend Anywhere for video consultations. It also offers registration, messaging, integration, and analytics and reporting platforms.
Induction Healthcare Group PLC Fundamentals Summary
INHC fundamental statistics | |
---|---|
Market cap | UK£7.04m |
Earnings (TTM) | -UK£3.24m |
Revenue (TTM) | UK£13.65m |
0.5x
P/S Ratio-2.2x
P/E RatioIs INHC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
INHC income statement (TTM) | |
---|---|
Revenue | UK£13.65m |
Cost of Revenue | UK£2.95m |
Gross Profit | UK£10.70m |
Other Expenses | UK£13.95m |
Earnings | -UK£3.24m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.035 |
Gross Margin | 78.40% |
Net Profit Margin | -23.78% |
Debt/Equity Ratio | 0% |
How did INHC perform over the long term?
See historical performance and comparison